Does eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy reduce the long-term risk of ulcers? A double-blinded randomized trial

2001 ◽  
Vol 120 (5) ◽  
pp. A143-A143
Author(s):  
F CHAN ◽  
K TO ◽  
J WU ◽  
W LEUNG ◽  
Y LEE ◽  
...  
1992 ◽  
Vol 102 (6) ◽  
pp. 1899-1905 ◽  
Author(s):  
David S. Loeb ◽  
Nicholas J. Talley ◽  
David A. Ahlquist ◽  
Herschel A. Carpenter ◽  
Alan R. Zinsmeister

2008 ◽  
Vol 67 (5) ◽  
pp. AB276
Author(s):  
Masafumi Kusunoki ◽  
Kazumasa Miyake ◽  
Mariko Umezawa ◽  
Tomotaka Shindo ◽  
Nobue Ueki ◽  
...  

2010 ◽  
Vol 0 (3) ◽  
pp. 23 ◽  
Author(s):  
Natalya Vladimirovna Chichasova ◽  
M Z Kanevskaya ◽  
G R Imametdinova ◽  
E V Igolkina ◽  
E L Nasonov

1974 ◽  
Vol 2 (5) ◽  
pp. 338-346 ◽  
Author(s):  
Valentin Stroescu ◽  
Carmen Georgescu ◽  
Radu Voiosu

In a double-blind, randomized trial on thirty-two patients affected by classical or definite rheumatoid arthritis, we have tried the effectiveness and safety of 500 mg/day oral diftalone versus 75 mg/day oral indomethacin for a period of six to twelve months treatment. Diftalone proved to be an effective and well tolerated anti-inflammatory drug in long-term treatment of rheumatoid arthritis. Its activity and safety is at least comparable to that achieved by the use of indomethacin.


The Lancet ◽  
1997 ◽  
Vol 350 (9083) ◽  
pp. 975-979 ◽  
Author(s):  
Francis KL Chan ◽  
Joseph JY Sung ◽  
SC Sydney Chung ◽  
KF To ◽  
MY Yung ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document